Entera Bio Ltd. (ENTX) stock

ENTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 8/30

$3.11−0.11 (-3.42%)

Close on Nov 13, 2026Market cap $538.47MP/E –Yield –

Entera Bio ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2020 it was -$10.94M. The highest annual figure on record is -$5.33M in fiscal 2016.

Period	Period end	Value	Change
FY2020	Dec 31, 2020	-$10.94M	–
FY2019	Dec 31, 2019	-$11.22M	–
FY2018	Dec 31, 2018	-$10.81M	–
FY2017	Dec 31, 2017	-$11.30M	–
FY2016	Dec 31, 2016	-$5.33M	–

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ENTX.

Advertisement
300 × 250

See a number that looks wrong?